Roux-en-Y gastric bypass versus duodenal switch in patients with body mass index ≥50 kg/m2: a systematic review and meta-analysis.

Ali Esparham, Samira Roohi, Ali Mehri, Abolfazl Ghahramani, Hengameh Anari Moghadam, Zhamak Khorgami
{"title":"Roux-en-Y gastric bypass versus duodenal switch in patients with body mass index ≥50 kg/m<sup>2</sup>: a systematic review and meta-analysis.","authors":"Ali Esparham, Samira Roohi, Ali Mehri, Abolfazl Ghahramani, Hengameh Anari Moghadam, Zhamak Khorgami","doi":"10.1016/j.soard.2024.08.042","DOIUrl":null,"url":null,"abstract":"<p><p>Currently, there is no consensus on the best bariatric surgery type for patients with body mass index (BMI) ≥50 kg/m<sup>2</sup>. This systematic review and meta-analysis aimed to compare outcomes of duodenal switch (DS) and Roux-en-Y gastric bypass (RYGB) in terms of weight loss, resolution of obesity-related comorbidities, and complications among patients with a BMI ≥50 kg/m<sup>2</sup>. A systematic search was conducted across databases including PubMed, Embase, Scopus, and Web of Science to include studies that compared outcomes of DS and RYGB in patients with BMI ≥50 kg/m<sup>2</sup>. A meta-analysis was carried out, alongside subgroup analyses based on the type of study and duration of follow-up. Twelve articles were included in this study (2678 patients, follow-up: 1-15 years). Patients with DS had 7.31 kg/m<sup>2</sup> higher BMI loss (95% CI: 5.59-9.03, P < .001) and 9.9% more total weight loss (95% CI: 4.47-15.28%, P < .001) compared with RYGB. The rate of complications, reoperation, mortality, and remission of comorbidities including diabetes, hypertension, dyslipidemia, and obstructive sleep apnea was not significantly different between DS and RYGB. Rate of malnutrition was 8.3% in the DS group compared with 1.2% in RYGB (OR: 5.53, 95% CI: 1.35-22.44, P = .02). In addition, 5.4% DS patients needed revisional surgery for malnutrition versus none in RYGB (OR: 6.1, 95% CI: 1.03-36.33, P = .05), and 24.6% of DS patients developed gallbladder disease needed cholecystectomy versus 4.5% after RYGB (OR: 6.36, 95% CI: 1.70-23.82, P = .01). DS leads to significantly higher BMI and total weight loss in patients with BMI ≥50 kg/m<sup>2</sup> but may be associated with a higher rate of major malnutrition and needed revisional surgery. These should be considered in surgical planning.</p>","PeriodicalId":94216,"journal":{"name":"Surgery for obesity and related diseases : official journal of the American Society for Bariatric Surgery","volume":" ","pages":""},"PeriodicalIF":0.0000,"publicationDate":"2024-09-16","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Surgery for obesity and related diseases : official journal of the American Society for Bariatric Surgery","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1016/j.soard.2024.08.042","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0

Abstract

Currently, there is no consensus on the best bariatric surgery type for patients with body mass index (BMI) ≥50 kg/m2. This systematic review and meta-analysis aimed to compare outcomes of duodenal switch (DS) and Roux-en-Y gastric bypass (RYGB) in terms of weight loss, resolution of obesity-related comorbidities, and complications among patients with a BMI ≥50 kg/m2. A systematic search was conducted across databases including PubMed, Embase, Scopus, and Web of Science to include studies that compared outcomes of DS and RYGB in patients with BMI ≥50 kg/m2. A meta-analysis was carried out, alongside subgroup analyses based on the type of study and duration of follow-up. Twelve articles were included in this study (2678 patients, follow-up: 1-15 years). Patients with DS had 7.31 kg/m2 higher BMI loss (95% CI: 5.59-9.03, P < .001) and 9.9% more total weight loss (95% CI: 4.47-15.28%, P < .001) compared with RYGB. The rate of complications, reoperation, mortality, and remission of comorbidities including diabetes, hypertension, dyslipidemia, and obstructive sleep apnea was not significantly different between DS and RYGB. Rate of malnutrition was 8.3% in the DS group compared with 1.2% in RYGB (OR: 5.53, 95% CI: 1.35-22.44, P = .02). In addition, 5.4% DS patients needed revisional surgery for malnutrition versus none in RYGB (OR: 6.1, 95% CI: 1.03-36.33, P = .05), and 24.6% of DS patients developed gallbladder disease needed cholecystectomy versus 4.5% after RYGB (OR: 6.36, 95% CI: 1.70-23.82, P = .01). DS leads to significantly higher BMI and total weight loss in patients with BMI ≥50 kg/m2 but may be associated with a higher rate of major malnutrition and needed revisional surgery. These should be considered in surgical planning.

查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
体重指数≥50 kg/m2 患者的 Roux-en-Y 胃旁路术与十二指肠转流术:系统综述和荟萃分析。
目前,关于体重指数(BMI)≥50 kg/m2患者的最佳减肥手术类型尚未达成共识。本系统综述和荟萃分析旨在比较十二指肠转位术(DS)和Roux-en-Y胃旁路术(RYGB)在体重指数(BMI)≥50 kg/m2患者的体重减轻、肥胖相关并发症的缓解和并发症方面的效果。我们在PubMed、Embase、Scopus和Web of Science等数据库中进行了系统性检索,以纳入对BMI≥50 kg/m2患者进行DS和RYGB疗效比较的研究。在进行荟萃分析的同时,还根据研究类型和随访时间进行了分组分析。本研究共纳入了12篇文章(2678名患者,随访时间:1-15年)。与 RYGB 相比,DS 患者的体重指数降低了 7.31 kg/m2(95% CI:5.59-9.03,P < .001),总重量降低了 9.9%(95% CI:4.47-15.28%,P < .001)。并发症发生率、再次手术率、死亡率以及糖尿病、高血压、血脂异常和阻塞性睡眠呼吸暂停等合并症的缓解率在 DS 和 RYGB 之间没有显著差异。DS 组营养不良率为 8.3%,而 RYGB 组为 1.2%(OR:5.53,95% CI:1.35-22.44,P = .02)。此外,5.4% 的 DS 患者因营养不良而需要再次手术,而 RYGB 患者无此需要(OR:6.1,95% CI:1.03-36.33,P = .05);24.6% 的 DS 患者因胆囊疾病而需要进行胆囊切除术,而 RYGB 患者仅为 4.5%(OR:6.36,95% CI:1.70-23.82,P = .01)。DS 可使体重指数(BMI)≥50 kg/m2 的患者的体重指数和总重量明显增加,但可能与较高的严重营养不良率和需要再次手术有关。在制定手术计划时应考虑到这些因素。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
自引率
0.00%
发文量
0
期刊最新文献
Comment on: endoscopic bariatric and metabolic therapies and its effect on MASLD: a review of the current literature. Comment on: The safety profile of one-anastomosis gastric bypass compared to Roux-en-Y gastric bypass: a Metabolic and Bariatric Surgery Accreditation and Quality Improvement Program analysis. Letter to the editor regarding "Racial disparities in the utilization and outcomes of robotic bariatric surgery: an 8-year analysis of Metabolic and Bariatric Surgery Accreditation Quality Improvement Program data". Liposomal bupivacaine for sleeve gastrectomy is associated with improved opioid outcomes and lower odds of opioid use disorder: claims-based analysis. Assessment of predictors of acute kidney injury and progression to chronic kidney disease following bariatric surgery.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1